143 related articles for article (PubMed ID: 28025093)
1. Varenicline improves motor and cognitive deficits and decreases depressive-like behaviour in late-stage YAC128 mice.
McGregor AL; D'Souza G; Kim D; Tingle MD
Neuropharmacology; 2017 Apr; 116():233-246. PubMed ID: 28025093
[TBL] [Abstract][Full Text] [Related]
2. Antidepressant Effects of Probucol on Early-Symptomatic YAC128 Transgenic Mice for Huntington's Disease.
de Paula Nascimento-Castro C; Wink AC; da Fônseca VS; Bianco CD; Winkelmann-Duarte EC; Farina M; Rodrigues ALS; Gil-Mohapel J; de Bem AF; Brocardo PS
Neural Plast; 2018; 2018():4056383. PubMed ID: 30186318
[TBL] [Abstract][Full Text] [Related]
3. Cognitive dysfunction precedes neuropathology and motor abnormalities in the YAC128 mouse model of Huntington's disease.
Van Raamsdonk JM; Pearson J; Slow EJ; Hossain SM; Leavitt BR; Hayden MR
J Neurosci; 2005 Apr; 25(16):4169-80. PubMed ID: 15843620
[TBL] [Abstract][Full Text] [Related]
4. Early pridopidine treatment improves behavioral and transcriptional deficits in YAC128 Huntington disease mice.
Garcia-Miralles M; Geva M; Tan JY; Yusof NABM; Cha Y; Kusko R; Tan LJ; Xu X; Grossman I; Orbach A; Hayden MR; Pouladi MA
JCI Insight; 2017 Dec; 2(23):. PubMed ID: 29212949
[TBL] [Abstract][Full Text] [Related]
5. Brain-Derived Neurotrophic Factor Prevents Depressive-Like Behaviors in Early-Symptomatic YAC128 Huntington's Disease Mice.
da Fonsêca VS; da Silva Colla AR; de Paula Nascimento-Castro C; Plácido E; Rosa JM; Farina M; Gil-Mohapel J; Rodrigues ALS; Brocardo PS
Mol Neurobiol; 2018 Sep; 55(9):7201-7215. PubMed ID: 29388082
[TBL] [Abstract][Full Text] [Related]
6. Dantrolene is neuroprotective in Huntington's disease transgenic mouse model.
Chen X; Wu J; Lvovskaya S; Herndon E; Supnet C; Bezprozvanny I
Mol Neurodegener; 2011 Nov; 6():81. PubMed ID: 22118545
[TBL] [Abstract][Full Text] [Related]
7. Laquinimod Treatment Improves Myelination Deficits at the Transcriptional and Ultrastructural Levels in the YAC128 Mouse Model of Huntington Disease.
Garcia-Miralles M; Yusof NABM; Tan JY; Radulescu CI; Sidik H; Tan LJ; Belinson H; Zach N; Hayden MR; Pouladi MA
Mol Neurobiol; 2019 Jun; 56(6):4464-4478. PubMed ID: 30334188
[TBL] [Abstract][Full Text] [Related]
8. Inactivation of adenosine A2A receptors reverses working memory deficits at early stages of Huntington's disease models.
Li W; Silva HB; Real J; Wang YM; Rial D; Li P; Payen MP; Zhou Y; Muller CE; Tomé AR; Cunha RA; Chen JF
Neurobiol Dis; 2015 Jul; 79():70-80. PubMed ID: 25892655
[TBL] [Abstract][Full Text] [Related]
9. A New VMAT-2 Inhibitor NBI-641449 in the Treatment of Huntington Disease.
Chen S; Zhang XJ; Xie WJ; Qiu HY; Liu H; Le WD
CNS Neurosci Ther; 2015 Aug; 21(8):662-71. PubMed ID: 26122704
[TBL] [Abstract][Full Text] [Related]
10. Dopaminergic manipulations and its effects on neurogenesis and motor function in a transgenic mouse model of Huntington's disease.
Choi ML; Begeti F; Oh JH; Lee SY; O'Keeffe GC; Clelland CD; Tyers P; Cho ZH; Kim YB; Barker RA
Neurobiol Dis; 2014 Jun; 66():19-27. PubMed ID: 24561069
[TBL] [Abstract][Full Text] [Related]
11. Gene therapy by proteasome activator, PA28γ, improves motor coordination and proteasome function in Huntington's disease YAC128 mice.
Jeon J; Kim W; Jang J; Isacson O; Seo H
Neuroscience; 2016 Jun; 324():20-8. PubMed ID: 26944602
[TBL] [Abstract][Full Text] [Related]
12. Prolonged exposure of rats to varenicline increases anxiety and alters serotonergic system, but has no effect on memory.
Zaccarelli-Magalhães J; Sandini TM; de Abreu GR; Petrocelli BM; Moreira N; Reis-Silva TM; Lebrun I; Flório JC; Ricci EL; Fukushima AR; Faria Waziry PA; de Souza Spinosa H
Pharmacol Biochem Behav; 2019 Jun; 181():1-8. PubMed ID: 30946884
[TBL] [Abstract][Full Text] [Related]
13. Striosome-matrix pathology and motor deficits in the YAC128 mouse model of Huntington's disease.
Lawhorn C; Smith DM; Brown LL
Neurobiol Dis; 2008 Dec; 32(3):471-8. PubMed ID: 18809498
[TBL] [Abstract][Full Text] [Related]
14. An automated and quantitative method to evaluate progression of striatal pathology in Huntington's disease transgenic mice.
Liang X; Wu J; Egorova P; Bezprozvanny I
J Huntingtons Dis; 2014; 3(4):343-350. PubMed ID: 25575955
[TBL] [Abstract][Full Text] [Related]
15. Treadmill exercise delays the onset of non-motor behaviors and striatal pathology in the CAG
Stefanko DP; Shah VD; Yamasaki WK; Petzinger GM; Jakowec MW
Neurobiol Dis; 2017 Sep; 105():15-32. PubMed ID: 28502806
[TBL] [Abstract][Full Text] [Related]
16. Behavioral and electrophysiological effects of the adenosine A2A receptor antagonist SCH 58261 in R6/2 Huntington's disease mice.
Domenici MR; Scattoni ML; Martire A; Lastoria G; Potenza RL; Borioni A; Venerosi A; Calamandrei G; Popoli P
Neurobiol Dis; 2007 Nov; 28(2):197-205. PubMed ID: 17720507
[TBL] [Abstract][Full Text] [Related]
17. Hyperactivation of D1 and A2A receptors contributes to cognitive dysfunction in Huntington's disease.
Tyebji S; Saavedra A; Canas PM; Pliassova A; Delgado-García JM; Alberch J; Cunha RA; Gruart A; Pérez-Navarro E
Neurobiol Dis; 2015 Feb; 74():41-57. PubMed ID: 25449908
[TBL] [Abstract][Full Text] [Related]
18. Motor deficits associated with Huntington's disease occur in the absence of striatal degeneration in BACHD transgenic mice.
Mantovani S; Gordon R; Li R; Christie DC; Kumar V; Woodruff TM
Hum Mol Genet; 2016 May; 25(9):1780-91. PubMed ID: 26908618
[TBL] [Abstract][Full Text] [Related]
19. Inhibition of DREAM-ATF6 interaction delays onset of cognition deficit in a mouse model of Huntington's disease.
López-Hurtado A; Burgos DF; González P; Dopazo XM; González V; Rábano A; Mellström B; Naranjo JR
Mol Brain; 2018 Mar; 11(1):13. PubMed ID: 29523177
[TBL] [Abstract][Full Text] [Related]
20. Solid Lipid Curcumin Particles Protect Medium Spiny Neuronal Morphology, and Reduce Learning and Memory Deficits in the YAC128 Mouse Model of Huntington's Disease.
Gharaibeh A; Maiti P; Culver R; Heileman S; Srinageshwar B; Story D; Spelde K; Paladugu L; Munro N; Muhn N; Kolli N; Rossignol J; Dunbar GL
Int J Mol Sci; 2020 Dec; 21(24):. PubMed ID: 33333883
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
